Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy

被引:98
作者
Bellini, Massimo [1 ]
Gambaccini, Dario [1 ]
Stasi, Cristina [2 ,3 ]
Urbano, Maria Teresa [1 ]
Marchi, Santino [1 ]
Usai-Satta, Paolo [4 ]
机构
[1] Univ Pisa, Dept Gastroenterol, Gastroenterol Unit, I-56124 Pisa, Italy
[2] Univ Florence, Dept Expt & Clin Med, I-50134 Florence, Italy
[3] Hlth Agcy Tuscany, Epidemiol Observ, I-50141 Florence, Italy
[4] P Brotzu Hosp, Gastrointestinal Unit, I-09124 Cagliari, Italy
关键词
Irritable bowel syndrome; Pathogenesis; Diagnosis; Therapy; RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; GASTROINTESTINAL SYMPTOMS; IDIOPATHIC CONSTIPATION; FECAL CALPROTECTIN; IMMUNE ACTIVATION; CLINICAL-TRIALS; COLONIC TRANSIT; ABDOMINAL-PAIN; DOUBLE-BLIND;
D O I
10.3748/wjg.v20.i27.8807
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Irritable bowel syndrome (IBS) is the most frequently diagnosed functional gastrointestinal disorder in primary and secondary care. It is characterised by abdominal discomfort, pain and changes in bowel habits that can have a serious impact on the patient's quality of life. The pathophysiology of IBS is not yet completely clear. Genetic, immune, environmental, inflammatory, neurological and psychological factors, in addition to visceral hypersensitivity, can all play an important role, one that most likely involves the complex interactions between the gut and the brain (gut-brain axis). The diagnosis of IBS can only be made on the basis of the symptoms of the Rome. criteria. Because the probability of organic disease in patients fulfilling the IBS criteria is very low, a careful medical history is critical and should pay particular attention to the possible comorbidities. Nevertheless, the severity of the patient's symptoms or concerns sometimes compels the physician to perform useless and/or expensive diagnostic tests, transforming IBS into a diagnosis of exclusion. The presence of alarming symptoms (fever, weight loss, rectal bleeding, significant changes in blood chemistry), the presence of palpable abdominal masses, any recent onset of symptoms in patient aged over 50 years, the presence of symptoms at night, and a familial history of celiac disease, colorectal cancer and/or inflammatory bowel diseases all warrant investigation. Treatment strategies are based on the nature and severity of the symptoms, the degree of functional impairment of the bowel habits, and the presence of psychosocial disorders. This review examines and discusses the pathophysiological aspects and the diagnostic and therapeutic approaches available for patients with symptoms possibly related to IBS, pointing out controversial issues and the strengths and weaknesses of the current knowledge. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:8807 / 8820
页数:14
相关论文
共 111 条
  • [1] Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder
    Aaron, LA
    Burke, MM
    Buchwald, D
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (02) : 221 - 227
  • [2] Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial
    Atkinson, W
    Sheldon, TA
    Shaath, N
    Whorwell, PJ
    [J]. GUT, 2004, 53 (10) : 1459 - 1464
  • [3] Bafutto Mauro, 2011, Arq. Gastroenterol., V48, P36, DOI 10.1590/S0004-28032011000100008
  • [4] Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome
    Barbara, G
    Stanghellini, V
    De Giorgio, R
    Cremon, C
    Cottrell, GS
    Santini, D
    Pasquinelli, G
    Morselli-Labate, AM
    Grady, EF
    Bunnett, NW
    Collins, SM
    Corinalidesi, R
    [J]. GASTROENTEROLOGY, 2004, 126 (03) : 693 - 702
  • [5] New pathophysiological mechanisms in irritable bowel syndrome
    Barbara, G
    De Giorgio, R
    Stanghellini, V
    Cremon, C
    Salvioli, B
    Corinaldesi, R
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 : 1 - 9
  • [6] The Immune System in Irritable Bowel Syndrome
    Barbara, Giovanni
    Cremon, Cesare
    Carini, Giovanni
    Bellacosa, Lara
    Zecchi, Lisa
    De Giorgio, Roberto
    Corinaldesi, Roberto
    Stanghellini, Vincenzo
    [J]. JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 17 (04) : 349 - 359
  • [7] Postinfectious Irritable Bowel Syndrome
    Barbara, Giovanni
    Cremon, Cesare
    Pallotti, Francesca
    De Giorgio, Roberto
    Stanghellini, Vincenzo
    Corinaldesi, Roberto
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2009, 48 : S95 - S97
  • [8] Proinflammatory Cytokine Gene Polymorphisms in Irritable Bowel Syndrome
    Barkhordari, Elham
    Rezaei, Nima
    Ansaripour, Bita
    Larki, Pegah
    Alighardashi, Maryam
    Ahmadi-Ashtiani, Hamid Reza
    Mahmoudi, Mahdi
    Keramati, Mohammad-Reza
    Habibollahi, Peiman
    Bashashati, Mohammad
    Ebrahimi-Daryani, Naser
    Amirzargar, Ali Akbar
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 (01) : 74 - 79
  • [9] Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?
    Barrett, Jacqueline S.
    Gibson, Peter R.
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2012, 5 (04): : 261 - 268
  • [10] Long-term treatment with probiotics in primary care patients with irritable bowel syndrome - a randomised, double-blind, placebo controlled trial
    Begtrup, Luise Molenberg
    de Muckadell, Ove B. Schaffalitzky
    Kjeldsen, Jens
    Christensen, Rene dePont
    Jarbol, Dorte Ejg
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (10) : 1127 - 1135